The soaring population and the government’s initiatives to provide the best healthcare infrastructure to its people has led to the creation of immense opportunities for the growth and development of pharmaceutical manufacturing in Saudi Arabia.

With the upliftment of pharmaceutical industry being a key inclusion in the National Transformation Programme (NTP) 2020 to achieve the Kingdom’s Vision 2030 goals, the pharmaceutical manufacturing sector in Saudi Arabia is poised for tremendous growth.

Recent industry reports indicate that the NTP is aiming for an increase in the role of local pharmaceutical manufacturing in the domestic market, from 18 to 40 percent of the market, and the pharmaceutical market in KSA is projected to expand by 10 percent annually between 2015 and 2020, to reach $13.6 billion.

Reports also note that the Saudi Ministry of Health plans to spend $18.5 billion on healthcare annually over the next 10 years, with a focus on improving the domestic manufacturing of medical devices and pharmaceuticals.